Concomitant Use of Direct Oral Anticoagulants and Pharmacokinetically-Interacting Antiarrhythmics and the Risk of Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Population-Based Cohort Study

被引：0
|
作者：
Meinert, Fabian Maximilian [1 ]
Dimakos, Jenny [2 ]
Cui, Ying [3 ]
Filion, Kristian B. [2 ]
Renoux, Christel [2 ]
Douros, Antonios [4 ]
机构：
[1] Charite Univ Med Berlin, Berlin, Germany
[2] McGill Univ, Montreal, PQ, Canada
[3] Lady Davis Inst, Montreal, PQ, Canada
[4] Charite Univ Med Berlin, Inst Clin Pharmacol & Toxicol, Berlin, Germany
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
357
引用
收藏
页码：134 / 135
页数：2
相关论文
共 50 条
  • [21] Risk of ischemic stroke associated with direct oral anticoagulants discontinuation on patients with non-valvular atrial fibrillation
    Thomsen, T. Alvaro
    Guadalupe, J. Mesa
    Huerta, C.
    de Burgos, A.
    Soriano, L. Cea
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
  • [22] Comparative safety and effectiveness of oral anticoagulants in patients with non-valvular atrial fibrillation and high risk of gastrointestinal bleeding: A nationwide French cohort study
    Lip, Gregory Y. H.
    Benamouzig, Robert
    Martin, Anne-Celine
    Pesce, Giancarlo
    Gusto, Gaelle
    Quignot, Nadia
    Khachatryan, Artak
    Dai, Feng
    Sedjelmaci, Fouad
    Chaves, Jose
    Subash, Rupesh
    Mokgokong, Ruth
    PLOS ONE, 2024, 19 (11):
  • [23] Inappropriate dose of direct oral anticoagulants therapy in patients with non-valvular atrial fibrillation
    Ito, M.
    Kaikita, K.
    Sueta, D.
    Ishii, M.
    Oimatsu, Y.
    Mitsuse, T.
    Arima, Y.
    Iwashita, S.
    Takahashi, A.
    Kanazawa, H.
    Kaneko, S.
    Kanemaru, Y.
    Kiyama, T.
    Yamabe, H.
    Tsujita, K.
    EUROPEAN HEART JOURNAL, 2018, 39 : 485 - 486
  • [24] Use of Anticoagulants in Patients With Non-Valvular Atrial Fibrillation Who Are at Risk of Falls
    Shanah, Layla
    Kabashneh, Sohaip
    Alkassis, Samer
    Ali, Hammad
    Mir, Tanveer
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (09)
  • [25] Dosing of Direct Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation and Renal Dysfunction
    Rymer, Jennifer A.
    Webb, Laura E.
    Wang, Tracy Y.
    CIRCULATION, 2021, 144
  • [26] The development and validation of a multivariable model to predict the bleeding risk score for patients with non-valvular atrial fibrillation using direct oral anticoagulants in the Arab population
    AlAmmari, Maha
    Sultana, Khizra
    Alturaiki, Abdulrahman
    Thomas, Abin
    AlBabtain, Monirah
    AlAyoubi, Fakahr
    Richi, Hanie
    PLOS ONE, 2021, 16 (05):
  • [27] Non-Vitamin K Oral Anticoagulants Assessment in High Risk of Bleeding Patients with Non-Valvular Atrial Fibrillation
    Cunha, Pedro Silva
    Monteiro, Andre Viveiros
    Cruz, Madalena Coutinho
    Malveiro, Paula
    Reis, Joao Pedro
    Portugal, Guilherme
    Dias, Ana
    Ferreira, Rui Cruz
    Oliveira, Mario Martins
    GERIATRICS, 2022, 7 (01)
  • [28] Association between oral anticoagulants and risk of dementia in patients with non-valvular atrial fibrillation
    Rahman, Alvi
    Michaud, Jonathan
    Dell'Aniello, Sophie
    Moodie, Erica
    Brophy, James M.
    Durand, Madeleine
    Guertin, Jason
    Boivin, Jean-Francois
    Renoux, Christel
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 631 - 631
  • [29] Low prevalence of colonic mucosal injury and bleeding in patients taking direct oral anticoagulants for non-valvular atrial fibrillation
    Osumi, Shun
    Abe, Koichiro
    Arizumi, Toshihiko
    Watari, Yuji
    Kozuma, Ken
    Aiso, Mitsuhiko
    Asaoka, Yoshinari
    Kodashima, Shinya
    Yamamoto, Takatsugu
    Tanaka, Atsushi
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (10) : 662 - 667
  • [30] Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort study
    Forslund, Tomas
    Wettermark, Bjorn
    Andersen, Morten
    Hjemdahl, Paul
    EUROPACE, 2018, 20 (03): : 420 - 428
12345